rEVO Biologics Overview

  • Year Founded
  • 1993

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 109

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 4

rEVO Biologics General Information

Description

Manufacturer of therapeutic proteins. The Company is engaged in the development and production of human therapeutic proteins through transgenic technology. It has produced ATryn, Antithrombin (Recombinant) a plasma-free antithrombin concentrate.

Contact Information

Formerly Known As
Gtc Biotherapeutics, Genzyme Transgenics Corporation, Gtc Biotherapeutics Inc, Genzyme Transgenics Corp
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 175 Crossing Boulevard
  • 4th Floor
  • Framingham, MA 01702
  • United States
+1 (508) 000-0000
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
LFB Group
Vertical(s)
Manufacturing, Life Sciences
Corporate Office
  • 175 Crossing Boulevard
  • 4th Floor
  • Framingham, MA 01702
  • United States
+1 (508) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

rEVO Biologics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore rEVO Biologics‘s full profile, request access.

Request a free trial

rEVO Biologics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of therapeutic proteins. The Company is engaged in the development and production of human therapeutic prot
Biotechnology
Framingham, MA
109 As of 2010
000.00
00.00 0000-00-00
000000&0 000.00

000000

t ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exerci
0000000000000
Florham Park, NJ
000 As of 0000
00000
00000000 00000

00000

la pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui o
0000000000000
Thousand Oaks, CA
00000 As of 0000
000.00
000000000 - 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

rEVO Biologics Competitors (9)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Phathom Pharmaceuticals Formerly VC-backed Florham Park, NJ 000 00000 00000000 00000
Amgen Formerly PE-Backed Thousand Oaks, CA 00000 000.00 000000000 - 000.00
CSL Behring Corporation King Of Prussia, PA 00000
Sorrento Therapeutics Formerly VC-backed San Diego, CA 000 00000 0000000000.
Gamida Cell Formerly VC-backed Boston, MA 000 0000 0000000000. 0000
You’re viewing 5 of 9 competitors. Get the full list »

rEVO Biologics Patents

  • 293

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 50

    Granted

  • 8

    Pending

  • 000

    Expiring in next 12 mo

rEVO Biologics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-9511087-B2 Use of antithrombin in extracorporeal membrane oxygenation Active 03-Aug-2012 000000000 00
US-20140194360-A1 Use of antithrombin in extracorporeal membrane oxygenation Active 03-Aug-2012 0000000000 0
US-20140206617-A1 Use of antithrombin in the treatment of pre-eclampsia Inactive 12-Mar-2012 000000000 0
EP-2279003-A2 An anti-cd137 antibody as an agent in the treatment of inflammatory conditions Inactive 01-May-2008 0000000000 0
US-20110229460-A1 Anti-cd137 antibody as an agent in the treatment of inflammatory conditions Inactive 01-May-2008 C07K16/464 00
To view rEVO Biologics’s complete patent history, request access »

rEVO Biologics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

rEVO Biologics Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore rEVO Biologics‘s full profile, request access.

Request a free trial

rEVO Biologics FAQs

  • When was rEVO Biologics founded?

    rEVO Biologics was founded in 1993.

  • Where is rEVO Biologics headquartered?

    rEVO Biologics is headquartered in Framingham, MA.

  • What is the size of rEVO Biologics?

    rEVO Biologics has 109 total employees.

  • What industry is rEVO Biologics in?

    rEVO Biologics’s primary industry is Biotechnology.

  • Is rEVO Biologics a private or public company?

    rEVO Biologics is a Private company.

  • What is the current valuation of rEVO Biologics?

    The current valuation of rEVO Biologics is 00.00.

  • What is rEVO Biologics’s current revenue?

    The current revenue for rEVO Biologics is 000000.

  • How much funding has rEVO Biologics raised over time?

    rEVO Biologics has raised $44.2M.

  • Who are rEVO Biologics’s investors?

    Sanofi Genzyme has invested in rEVO Biologics.

  • Who are rEVO Biologics’s competitors?

    Phathom Pharmaceuticals, Amgen, CSL Behring, Sorrento Therapeutics, and Gamida Cell are some of the 9 competitors of rEVO Biologics.

  • When was rEVO Biologics acquired?

    rEVO Biologics was acquired on 02-Dec-2010.

  • Who acquired rEVO Biologics?

    rEVO Biologics was acquired by LFB Group.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »